Topology and Regulation of Ganglioside Metabolism — Function and Pathobiochemistry of Sphingolipid Activator Proteins

  • K. Sandhoff
  • G. van Echten
Conference paper
Part of the Colloquium der Gesellschaft für Biologische Chemie 22.–24. April 1993 in Mosbach/Baden book series (MOSBACH, volume 44)

Abstract

Glycosphingolipids (GSL) are amphiphilic plasma membrane components characteristic of vertebrate tissues (Svennerholm 1984; Ledeen and Yu 1982; van Echten and Sandhoff 1989).

Keywords

Gauche Disease Lysosomal Compartment Golgi Vesicle Metachromatic Leukodystrophy Gauche Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barranger YA, Ginns EJ (1989) Glucosylceramide lipidosis: Gaucher Disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic bases of inherited disease. 6th ed. vol. II, Mc Graw-Hill, New York, pp 1677–1698Google Scholar
  2. Berent SL, Radin NS (1981) Mechanism of activation of glucocerebrosidase by co-β-glucosi- dase (glucosidase activator protein). Biochim Biophys Acta 664: 572–582PubMedGoogle Scholar
  3. O’Brien JS, Kretz KA, Dewji N, Wenger DA, Esch F, Fluharty AL (1988) Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus. Science 241:1098–1101PubMedCrossRefGoogle Scholar
  4. O’Brien JS (1989) β-Galactosidase deficiency (GM1, gangliosidosis, galactosialidosis, and Morquio Syndrome Type B); ganglioside sialidase deficiency (Mucolipidosis (IV). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic bases of inherited disease 6th ed., vol. II., Mc Graw-Hill, New York, pp 1797–1806Google Scholar
  5. Coste H, Martel M-B, Got R (1986) Topology of glusosylceramide synthesis in Golgi membranes from porcine submaxillary glands. Biochim Biophys Acta 858:6–12PubMedCrossRefGoogle Scholar
  6. Deutscher SL, Hirschberg CB (1986) Mechanism of galactosylation in the Golgi apparatus. J Biol Chem 261:96–100PubMedGoogle Scholar
  7. Fishman PH, Brady RO (1976) Biosynthesis and function of gangliosides. Science 194:906–915PubMedCrossRefGoogle Scholar
  8. Fürst W, Sandhoff K (1992) Activator proteins and topology of lysosomal sphingolipid catabo- lism. Biochim Biophys Acta 1126:1–16PubMedGoogle Scholar
  9. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S (1988) The mannose-6-phosphate receptor and the biogenesis of lysosomes. Cell 52:329–341PubMedCrossRefGoogle Scholar
  10. Hashimoto Y, Suzuki A, Yamakawa T, Miyashita N, Moriwaki K (1983) Expression of GM1 and GDI a in mouse liver is linked to the H2 complex on chromosome 17. J Biochem 94:2043–2048PubMedGoogle Scholar
  11. Ho MW, Light ND (1973) Glucocerebrosidase: reconstitution from macromolecular components depends on acidic phospholipids. Biochem J 136:821–823PubMedGoogle Scholar
  12. Ho MW (1975) Specificity of low molecular weight glycoprotein effector of lipid glycosidase. FEBS Lett 53:243–247PubMedCrossRefGoogle Scholar
  13. Ho MW, Rigby M (1975) Glucocerebrosidase. Stoichiometry of association between effector and catalytic proteins. Biochim Biophys Acta 397:267–273PubMedGoogle Scholar
  14. Holtschmidt H, Sandhoff K, Kwon HY, Harzer K, Nakano T, Suzuki K (1991) Sulfatide activator protein: alternative splicing generates three mRNAs and a newly found mutation responsible for a clinical disease. J Biol Chem 266:7556–7560PubMedGoogle Scholar
  15. Hopkins CR, Gibson A, Shipman M, Miller K (1990) Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature 346:335–339PubMedCrossRefGoogle Scholar
  16. Harzer K, Paton BC, Poulos A, Kustermann-Kuhn B, Roggendorf W, Grisar T, Popp M (1989) Sphingolipid activator protein (SAP) deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr 149:31–39PubMedCrossRefGoogle Scholar
  17. Iber H, Kaufmann R, Pohlentz G, Schwarzmann G, Sandhoff K (1989) Identity of GA1-, GM la- and GDlb synthase in Golgi vesicles from rat liver. FEBS Lett 248:18–22PubMedCrossRefGoogle Scholar
  18. Iber H, Sandhoff K (1989) Identity of GDlc, GTla and GQlb synthase in Golgi vesicles from rat liver. FEBS Lett 254:124–128PubMedCrossRefGoogle Scholar
  19. Iber H, van Echten G, Klein RA, Sandhoff K (1990) pH-Dependent changes of ganglioside biosynthesis in neuronal cell culture. Eur J Cell Biol 52:236–240PubMedGoogle Scholar
  20. Iber H, van Echten G, Sandhoff K (1991) Substrate specificity of α 2 → 3 sialytransferases in ganglioside biosynthesis of rat liver Golgi. Eur J Biochem 195:115–120PubMedCrossRefGoogle Scholar
  21. Iber H, Zacharias C, Sandhoff K (1992a) The c-series gangliosides GT3, GT2 and GPlc are formed in rat liver Golgi by the same set of glycosyltransferases that catalyze the biosynthesis of asialo, a-, and b-series gangliosides. Glycobiology 2:137–142PubMedCrossRefGoogle Scholar
  22. Iber H, van Echten G, Sandhoff K (1992b) Fractionation of primary cultured neurons: distribution of sialyltransferases involved in ganglioside biosynthesis. J Neurochem 58:1533–1537PubMedCrossRefGoogle Scholar
  23. Kok JW, Babia T, Hoekstra D (1991) Sorting of sphingolipids in the endocytic pathway of HT 29 cells. J Cell Biol 114:231–239PubMedCrossRefGoogle Scholar
  24. Koval M, Pagano RE (1989) Lipid recycling between the plasma membrane and intracellular compartments: transport and metabolism of fluorescent sphingomyelin analogs in cultured fibroblasts. J Cell Biol 108:2169–2181PubMedCrossRefGoogle Scholar
  25. Koval M, Pagano RE (1990) Sorting of an internalized plasma membrane lipid between recycling and degradative pathways in normal and Niemann-Pick, type A fibroblasts. J Cell Biol 111:429–442PubMedCrossRefGoogle Scholar
  26. Kretz KA, Carson GS, Morimoto S, Kishimoto Y, Fluharty AL, O’Brien JS (1990) Characterization of a mutation in a family with saposin B deficiency: a glucosylation site defect. Proc Natl Acad Sci USA 87:2541–2544PubMedCrossRefGoogle Scholar
  27. Ledeen RW, Yu RK (1982) New strategies for detection and resolution of minor gangliosides as applied to brain fucogangliosides. Methods Enzymol 83:139–189PubMedCrossRefGoogle Scholar
  28. Li S-C, Sonnino S, Tettamanti G, Li Y-T (1988) Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids. J Biol Chem 263:6588–6591PubMedGoogle Scholar
  29. Mandon EC, van Echten G, Birk R, Schmidt RR, Sandhoff K (1991) Sphingolipid biosynthesis in cultured neurons. Downregulation of serine palmitoyltransferase by sphingoid bases. Eur J Biochem 198:667–674PubMedCrossRefGoogle Scholar
  30. Mandon E, Ehses I, Rother J, van Echten G, Sandhoff K (1992) Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase and sphinganine N-acyltransferase in mouse liver. J Biol Chem 267:11144–11148PubMedGoogle Scholar
  31. McKanna JA, Haigier HT, Cohen S (1979) Hormone receptor topology and dynamics: morphological analysis using ferritin-labeled epidermal growth factor. Proc Natl Acad Sci USA 76:5689–5693PubMedCrossRefGoogle Scholar
  32. Mehl E, Jatzkewitz H (1964) Eine Cerebrosidsulfatase aus Schweineniere. Hoppe-Seyler’s Z Physiol Chem 339:260–276PubMedCrossRefGoogle Scholar
  33. Meier EM, Schwarzmann G, Fürst W, Sandhoff K (1991) The human GM2 activator protein: a substrate-specific cofactor of hexosaminidase A. J Biol Chem 266:1879–1887PubMedGoogle Scholar
  34. Merrill AH, Wang E (1986) Biosynthesis of long-chain (sphingoid) bases from serine by LM cells. J Biol Chem 261:3764–3769PubMedGoogle Scholar
  35. Morré DJ, Kartenbeck J, Franke WW (1979) Membrane flow and interconversions among en- domembranes. Biochim Biophys Acta 559:71–152PubMedGoogle Scholar
  36. Moser W, Moser AB, Chen WW, Schram AW (1989) Ceramidase deficiency: Farber lipogra- nulomatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic bases of inherited disease, 6th ed., vol. II. Mc Graw-Hill, New York, pp 1645–1654Google Scholar
  37. Nagai Y, Nakaishi H, Sanai Y (1986) Gene transfer as a novel approach to the gene-controlled mechanism of the cellular expression of glycosphingolipids. Chem Phys Lipids 42:91–103PubMedCrossRefGoogle Scholar
  38. Nakakuma H, Sanai Y, Shiroki K, Nagai Y (1984) Gene-regulated expression of glycolipids: appearance of GD3 ganglioside in rat cells on transfection with transforming gene E 1 of human adenovirus type 12 DNA and its transcriptional subunits. J Biochem 96:1471–1480Google Scholar
  39. Nakano T, Sandhoff K, Stümper J, Chrisomanou H, Suzuki K (1989) Structure of full-length cDNA coding for sulfatide activator, a co-β-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator. J Biochem (Tokyo) 105:152–154Google Scholar
  40. Ong DE, Brady RN (1973) In vivo studies on the introduction of the 4-t-double bond of the sphingenene moiety of rat brain ceramides. J Biol Chem 248:3884–3888PubMedGoogle Scholar
  41. Pohlentz G, Klein D, Schwarzmann G, Schmitz D, Sandhoff K (1988) Both GA2-, GM2, and GD2 synthases and GM lb, GDI a and GTlb synthases are single enzymes in Golgi vesicles from rat liver. Proc Natl Sci USA 85:7044–7048CrossRefGoogle Scholar
  42. Rafi MA, Zhang X-L, De Gala G, Wenger DA (1990) Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy. Biochem Biophys Res Commun 166:1017–1023PubMedCrossRefGoogle Scholar
  43. Renfrew CA, Hubbard AL (1991) Degradation of epidermal growth factor receptor in rat liver. Membrane topology through the lysosomal pathway. J Biol Chem 266:21265–21273PubMedGoogle Scholar
  44. Rother J, van Echten G, Schwarzmann G, Sandhoff K (1992) Biosynthesis of sphingolipids: di- hydroceramide and not sphinganine is desaturated by cultured cells. Biochem Biophys Res Commun 189:14–20PubMedCrossRefGoogle Scholar
  45. Sandhoff K, Christomanou H (1979) Biochemistry and genetics of gangliosidoses. Hum Genet 50:107–143PubMedCrossRefGoogle Scholar
  46. Sandhoff K, Conzelmann E, Neufeld ET, Kaback MM, Suzuki K (1989) The GM2-gangliosi- dosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic bases of inherited disease, 6th ed., vol. II. Mc Graw-Hill, New York, pp 1807–1839Google Scholar
  47. Sandhoff K, van Echten G, Schröder M, Schnabel D, Suzuki K (1992) Metabolism of glycolipids. The role of glycolipid-binding proteins in the function and pathobiochemistry of lyso- somes. Biochem Soc Trans 20:695–699PubMedGoogle Scholar
  48. Schnabel D, Schröder M, Sandhoff K (1991) Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett 284:57–59PubMedCrossRefGoogle Scholar
  49. Schnabel D, Schröder M, Fürst W, Klein A, Hurwitz R, Zenk T, Weber G, Harzer K, Paton B, Poulos A, Suzuki K, Sandhoff K (1992) Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J Biol Chem 267:3312–3315PubMedGoogle Scholar
  50. Schwarzmann G, Sandhoff K (1990) Metabolism and intracellular transport of glycosphingoli- pids. Perspectives in biochemistry, Biochemistry 29:10865–10871PubMedCrossRefGoogle Scholar
  51. Stoffel W, Le Kim D, Sticht G (1968) Metabolism of sphingosine bases: biosynthesis of dihy- drosphingosine in vitro. Hoppe-Seyler’s Z Physiol Chem 349:664–670PubMedCrossRefGoogle Scholar
  52. Stoffel W, Bister K (1974) Desaturation of sphinganine. Ceramide and sphingomyelin metabolism in the rat and in BHK 21 cells in tissue culture. Hoppe-Seyler’s Z Physiol Chem 355:911–923PubMedCrossRefGoogle Scholar
  53. Svennerholm L (1984) Biological significance of gangliosides. In: Dreyfus H, Massarelli R, Freysz L, Rebel G (eds) Cellular and pathological aspects of glycoconjugate metabolism, vol 126. INSERM, France, pp 21–44Google Scholar
  54. Thompson LK, Horowitz PM, Bently KL, Thomas DD, Alderete JF, Klebe RJ (1986) Localization of the ganglioside-binding site of fibronectin. J Biol Chem 261:5209–5214PubMedGoogle Scholar
  55. Tiemeyer M, Yasuda Y, Schnaar RL (1989) Ganglioside-specific binding protein on rat brain membranes. J Biol Chem 264:1671–1681PubMedGoogle Scholar
  56. Trinchera M, Fabbri M, Ghidoni R (1991) Topography of gly cosy transferases involved in the initial glycosylations of gangliosides. J Biol Chem 266:20907–20912PubMedGoogle Scholar
  57. van Echten G, Sandhoff K (1989) Modulation of ganglioside biosynthesis in primary cultured neurons. J Neurochem 52:207–214PubMedCrossRefGoogle Scholar
  58. van Echten G, Iber H, Stotz H, Takatsuki A, Sandhoff K (1990a) Uncoupling of ganglioside biosynthesis by Brefeldin A. Eur J Cell Biol 51:135–139PubMedGoogle Scholar
  59. van Echten G, Birk R, Brenner-Weiss G, Schmidt RR, Sandhoff K (1990b) Modulation of sphingolipid biosynthesis in primary cultured neurons by long-chain bases. J Biol Chem 265:9333–9339PubMedGoogle Scholar
  60. Vogel A, Schwarzmann G, Sandhoff K (1991) Glycosphingolipid specificity of the human sul- fatide activator protein. Eur J Biochem 200:591–597PubMedCrossRefGoogle Scholar
  61. Wessling-Resnick M, Braell WA (1990) The sorting and segregation mechanism of the en- docytic pathway is functional in a cell-free system. J Biol Chem 265:690–699PubMedGoogle Scholar
  62. Yusuf HKM, Schwarzmann G, Pohlentz G, Sandhoff K (1987) Oligosialogangliosides inhibit GM2- and GD3-synthesis in isolated Golgi vesicles from rat liver. Hoppe Seyler’s Z Physiol Chem 368:455–462CrossRefGoogle Scholar
  63. Zhang X-L, Rafi MA, De Gala G, Wenger DA (1990) Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency. Proc Natl Acad Sci USA 87:1426–1430PubMedCrossRefGoogle Scholar
  64. Zhang X-L, Rafi MA, De Gala G, Wenger DA (1991) The mechanism for a 33-nucleotide insertion in messenger RNA causing sphingolipid activator protein (SAP-1) — deficient metachromatic leukodystrophy. Hum Genet 87:211–215PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • K. Sandhoff
    • 1
  • G. van Echten
    • 1
  1. 1.Institut für Organische Chemie und Biochemie der Universität BonnBonn 1Germany

Personalised recommendations